mitomycin has been researched along with Myopia in 106 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Myopia: A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the safety and efficacy of 5 seconds of mitomycin-C (MMC) application during photorefractive keratectomy (PRK) for low myopia." | 9.17 | Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia. ( Almasi-Nasrabadi, M; Eslani, M; Ramezanzadeh, M; Rezazadeh, P; Shojaei, A; Soleyman-Jahi, S, 2013) |
| "To compare photorefractive keratectomy (PRK) with prophylactic use of mitomycin C (MMC) and LASIK in custom surgeries for myopic astigmatism." | 9.13 | Photorefractive keratectomy with mitomycin C versus LASIK in custom surgeries for myopia: a bilateral prospective randomized clinical trial. ( Campos, M; Wallau, AD, 2008) |
| "The results show the efficacy of mitomycin-C in preventing corneal haze after treatment of high myopia with PRK." | 9.11 | Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study. ( Fotouhi, A; Hashemi, H; Kheiltash, A; Taheri, SM, 2004) |
| "This review details the current understanding of the mechanism of action and corneal effects of mitomycin C (MMC) for prophylactic prevention of stromal fibrosis after photorefractive keratectomy (PRK), and includes discussion of available information on dosage and exposure time recommended for MMC during PRK." | 9.05 | Biological effects of mitomycin C on late corneal haze stromal fibrosis following PRK. ( Carlos de Oliveira, R; Wilson, SE, 2020) |
| "02% mitomycin C (MMC) used for up to 2 minutes after surface ablation for correction of myopia." | 8.87 | Meta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02% mitomycin C. ( Chen, SH; Feng, YF; Stojanovic, A; Wang, QM, 2011) |
| "Postoperative complications related to overfiltration were less frequent after canaloplasty with mitomycin C." | 8.12 | Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022) |
| "ASLA-SCHWIND TransPRK without mitomycin-C appears to be safe as well as effective and accurate for high myopia." | 8.02 | Efficacy and safety of single-step transepithelial photorefractive keratectomy with the all-surface laser ablation SCHWIND platform without mitomycin-C for high myopia: A retrospective study of 69 eyes. ( Bloch, F; El Nar, A; Giral, JB; Goetz, C; Lhuillier, L; Perone, JM; Sot, M; Vermion, JC; Zevering, Y, 2021) |
| "To compare efficacy and safety of single-step transepithelial photorefractive keratectomy (PRK) with or without mitomycin C (MMC) in patients with mild to moderate myopia." | 7.88 | Comparison of Single-Step Transepithelial Photorefractive Keratectomy With or Without Mitomycin C in Mild to Moderate Myopia. ( Adib-Moghaddam, S; Grentzelos, MA; Kymionis, GD; Soleyman-Jahi, S; Tefagh, G; Tofighi, S, 2018) |
| "The purpose of this study was to evaluate the predictability and stability of laser-assisted subepithelial keratectomy (LASEK) with mitomycin C (MMC) in correction of high myopia (≤-6." | 7.85 | Predictability and stability of laser-assisted subepithelial keratectomy with mitomycin C for the correction of high myopia. ( Chen, IN; Fan, MCY; Iu, LPL; Lai, JSM, 2017) |
| "To evaluate the long-term outcomes of laser-assisted subepithelial keratomileusis (LASEK) with intraoperative use of mitomycin C (MMC) performed on thin corneas for the correction of myopia." | 7.85 | Long-term Follow-up of LASEK With Mitomycin C Performed to Correct Myopia in Thin Corneas. ( Drake Rodriguez-Casanova, P; Garcia-Gonzalez, M; Rodero, A; Rodriguez-Perez, I; Teus, MA, 2017) |
| "Photorefractive keratectomy (PRK) is a safe and effective surgical keratorefractive technique which is done with the application of mitomycin-C (MMC) in cases of high myopia to prevent the formation of corneal haze This study was conducted to evaluate 3-year visual acuity and quality outcomes of PRK-MMC in high myopia." | 7.85 | Photorefractive Keratectomy With Mitomycin-C for High Myopia: Three Year Follow-Up Results. ( Asgari, S; Hashemi, H; Pir, P; Salimi, Y, 2017) |
| "To examine the refractive and visual outcome of laser-assisted subepithelial keratomileusis (LASEK) with mitomycin C(MMC) in eyes with myopic astigmatism ≥2." | 7.80 | Laser-assisted subepithelial keratomileusis with mitomycin C for myopic astigmatism ≥2.00 diopters using a Zeiss MEL 80 Excimer. ( Ardjomand, N; El-Shabrawi, Y; Frings, A; Vidic, B, 2014) |
| "To evaluate the safety and efficacy of photorefractive keratectomy (PRK) with Mitomycin C (MMC) for the treatment of severe pediatric anisometropia and amblyopia resistant to more conservative treatment modalities." | 7.78 | Pediatric PRK (PhotoRefractive Keratectomy) with Mitomycin C (MCC) for Persistent Anisometropic Amblyopia. A Case Report. ( Arnold, RW; Crawford, CM; Frazier, TC; Mazzoli, RA; Raymond, WR; Torres, MF, 2012) |
| "To report the use of photorefractive keratectomy (PRK) with mitomycin-C (MMC) to treat concomitant myopia and visually significant infiltrates associated with epidemic keratoconjunctivitis (EKC)." | 7.78 | Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis. ( Alevi, D; Barsam, A; Donnenfeld, ED; Kruh, J; Perry, HD; Prince, J, 2012) |
| "To report topography-guided photorefractive keratectomy (PRK) with mitomycin C (MMC) after penetrating keratoplasty for keratoconus." | 7.75 | Topography-guided (NIDEK customized aspheric treatment zone) photorefractive keratectomy with mitomycin C after penetrating keratoplasty for keratoconus: case report. ( Alves, MR; Barreto, J; Bechara, SJ; Nakano, M; Netto, MV; Reis, A, 2009) |
| "To evaluate the safety and efficacy of photorefractive keratectomy (PRK) with intraoperative mitomycin C (MMC) after deep anterior lamellar keratoplasty (DALK) for keratoconus." | 7.74 | Photorefractive keratectomy with mitomycin C after deep anterior lamellar keratoplasty for keratoconus. ( Leccisotti, A, 2008) |
| "To evaluate the efficacy and safety of prophylactic mitomycin C (MMC) during photorefractive keratectomy (PRK) over LASIK flaps for the treatment of residual refractive errors following LASIK." | 7.74 | Photorefractive keratectomy with 0.02% mitomycin C for treatment of residual refractive errors after LASIK. ( Drake, A; Herzig, S; Srinivasan, S, 2008) |
| "We report a case of controlled buccal pemphigus vulgaris with compound moderate myopia with astigmatism that was treated with photorefractive keratectomy with mitomycin-C (PRK+MMC) in both eyes." | 7.74 | Photorefractive keratectomy with mitomycin-C for the treatment of compound moderate myopia with astigmatism in buccal pemphigus vulgaris. ( Kheiltash, A; Taheri, SM, 2007) |
| "To compare the postoperative pain, visual recovery, and outcomes of flap-on and flap-off epithelial laser in situ keratomileusis (epi-LASIK) with mitomycin-C (MMC)." | 6.76 | Wavefront-guided epithelial laser in situ keratomileusis with mitomycin-C for myopia and myopic astigmatism: flap-on versus flap-off technique. ( Ang, RE; Hernandez, JA; Reyes, KB; Tchah, H, 2011) |
| " However, for moderate myopia and shallow depth, low dosing appears to be equally effective." | 5.35 | Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. ( Krueger, RR; Thornton, I; Xu, M, 2008) |
| "To evaluate ocular straylight before and after photorefractive keratectomy (PRK) for low myopia with and without topical mitomycin (MMC) treatment." | 5.22 | Intraocular straylight before and after low myopic photorefractive keratectomy with and without mitomycin C. ( Bechara, SJ; Crestana, FP; Netto, MV; Parede, TR; Torricelli, AA, 2016) |
| "To compare visual outcomes following photorefractive keratectomy (PRK), PRK with mitomycin C (MMC-PRK), and LASEK in moderate and high myopia in military personnel." | 5.19 | The U.S. Army Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK in moderate to high myopia. ( Bower, KS; Edwards, JD; Ryan, DS; Sia, RK; Stutzman, RD, 2014) |
| "To assess the effect of mitomycin-C (MMC) on the tear film, corneal biomechanics, and surface irregularity in surface ablation (photorefractive keratectomy [PRK]) for low to moderate myopia." | 5.19 | Effects of mitomycin-C on tear film, corneal biomechanics, and surface irregularity in mild to moderate myopic surface ablation: preliminary results. ( Abdolahinia, T; Ashrafi, E; Jabbarvand, M; Mir-AbouTalebi, M; Mohammadi, SF; Norouzi, N, 2014) |
| "To assess the effects of adjuvant mitomycin C (MMC) on tear function tests after photorefractive keratectomy (PRK) for myopia." | 5.17 | The effects of mitomycin C on tear function after photorefractive keratectomy: a contralateral comparative study. ( Farahi, A; Hashemi, H; Mehravaran, S, 2013) |
| "To evaluate the safety and efficacy of 5 seconds of mitomycin-C (MMC) application during photorefractive keratectomy (PRK) for low myopia." | 5.17 | Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia. ( Almasi-Nasrabadi, M; Eslani, M; Ramezanzadeh, M; Rezazadeh, P; Shojaei, A; Soleyman-Jahi, S, 2013) |
| "To compare 1-year follow-up results of photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK) for custom correction of myopia." | 5.14 | One-year outcomes of a bilateral randomised prospective clinical trial comparing PRK with mitomycin C and LASIK. ( Campos, M; Wallau, AD, 2009) |
| "To compare photorefractive keratectomy (PRK) with prophylactic use of mitomycin C (MMC) and LASIK in custom surgeries for myopic astigmatism." | 5.13 | Photorefractive keratectomy with mitomycin C versus LASIK in custom surgeries for myopia: a bilateral prospective randomized clinical trial. ( Campos, M; Wallau, AD, 2008) |
| "To evaluate the anti-haze effect and visual outcome after intraoperative mitomycin C (MMC) use during photorefractive keratectomy (PRK) in myopia or myopic astigmatism patients." | 5.12 | Mitomycin C for the prevention of corneal haze in photorefractive keratectomy: a meta-analysis and trial sequential analysis. ( Chang, YM; Chien, KH; Lee, CH; Liang, CM; Weng, TH, 2021) |
| "The results show the efficacy of mitomycin-C in preventing corneal haze after treatment of high myopia with PRK." | 5.11 | Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study. ( Fotouhi, A; Hashemi, H; Kheiltash, A; Taheri, SM, 2004) |
| "To evaluate the results of the prophylactic use of mitomycin-C to inhibit haze formation after excimer laser photorefractive keratectomy (PRK) for medium and high myopia in eyes that were not good candidates for laser in situ keratomileusis (LASIK)." | 5.10 | Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. ( Carones, F; Scandola, E; Vacchini, L; Vigo, L, 2002) |
| "This review details the current understanding of the mechanism of action and corneal effects of mitomycin C (MMC) for prophylactic prevention of stromal fibrosis after photorefractive keratectomy (PRK), and includes discussion of available information on dosage and exposure time recommended for MMC during PRK." | 5.05 | Biological effects of mitomycin C on late corneal haze stromal fibrosis following PRK. ( Carlos de Oliveira, R; Wilson, SE, 2020) |
| "02% mitomycin C (MMC) used for up to 2 minutes after surface ablation for correction of myopia." | 4.87 | Meta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02% mitomycin C. ( Chen, SH; Feng, YF; Stojanovic, A; Wang, QM, 2011) |
| "Trabeculectomy with mitomycin C was the most common primary surgery performed in Thai patients with JOAG, and successfully reduced intraocular pressure without significant complications." | 4.31 | Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand. ( Annopawong, K; Friedman, DS; Seresirikachorn, K; Thiamthat, W; Vu, DM; Wanichwecharungruang, B, 2023) |
| "Postoperative complications related to overfiltration were less frequent after canaloplasty with mitomycin C." | 4.12 | Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma? ( Dietlein, TS; Dooling, V; Lappas, A, 2022) |
| "This work aimed to study the changes in corneal optical density measured with confocal microscopy in eyes treated with laser-assisted subepithelial keratectomy (LASEK) and intraoperative mitomycin C (MMC) to correct myopia." | 4.02 | Effect of Laser-assisted Subepithelial Keratectomy with Mitomycin C on Corneal Optical Density Measured with Confocal Microscopy. ( Cañadas, P; Cañones-Zafra, R; Garcia-Gonzalez, M; Gros-Otero, J; Rodriguez-Perez, I; Teus, MA, 2021) |
| "ASLA-SCHWIND TransPRK without mitomycin-C appears to be safe as well as effective and accurate for high myopia." | 4.02 | Efficacy and safety of single-step transepithelial photorefractive keratectomy with the all-surface laser ablation SCHWIND platform without mitomycin-C for high myopia: A retrospective study of 69 eyes. ( Bloch, F; El Nar, A; Giral, JB; Goetz, C; Lhuillier, L; Perone, JM; Sot, M; Vermion, JC; Zevering, Y, 2021) |
| "To compare efficacy and safety of single-step transepithelial photorefractive keratectomy (PRK) with or without mitomycin C (MMC) in patients with mild to moderate myopia." | 3.88 | Comparison of Single-Step Transepithelial Photorefractive Keratectomy With or Without Mitomycin C in Mild to Moderate Myopia. ( Adib-Moghaddam, S; Grentzelos, MA; Kymionis, GD; Soleyman-Jahi, S; Tefagh, G; Tofighi, S, 2018) |
| "Photorefractive keratectomy (PRK) is a safe and effective surgical keratorefractive technique which is done with the application of mitomycin-C (MMC) in cases of high myopia to prevent the formation of corneal haze This study was conducted to evaluate 3-year visual acuity and quality outcomes of PRK-MMC in high myopia." | 3.85 | Photorefractive Keratectomy With Mitomycin-C for High Myopia: Three Year Follow-Up Results. ( Asgari, S; Hashemi, H; Pir, P; Salimi, Y, 2017) |
| "To longitudinally compare the visual and refractive outcomes and changes in corneal thickness between femtosecond-assisted sub-Bowmen keratomileusis (SBK) and photorefractive keratectomy (PRK) with mitomycin C in eyes with high myopia." | 3.85 | Longitudinal comparison of femtosecond-assisted sub-Bowman keratomileusis versus photorefractive keratectomy for high myopia. ( Chan, TCY; Jhanji, V; Mak, S; Yu, MCY, 2017) |
| "To evaluate the long-term outcomes of laser-assisted subepithelial keratomileusis (LASEK) with intraoperative use of mitomycin C (MMC) performed on thin corneas for the correction of myopia." | 3.85 | Long-term Follow-up of LASEK With Mitomycin C Performed to Correct Myopia in Thin Corneas. ( Drake Rodriguez-Casanova, P; Garcia-Gonzalez, M; Rodero, A; Rodriguez-Perez, I; Teus, MA, 2017) |
| "The purpose of this study was to evaluate the predictability and stability of laser-assisted subepithelial keratectomy (LASEK) with mitomycin C (MMC) in correction of high myopia (≤-6." | 3.85 | Predictability and stability of laser-assisted subepithelial keratectomy with mitomycin C for the correction of high myopia. ( Chen, IN; Fan, MCY; Iu, LPL; Lai, JSM, 2017) |
| "To compare the variance in manifest refraction spherical equivalent (MRSE) after photorefractive keratectomy (PRK) with mitomycin-C (MMC), PRK without MMC, and laser in situ keratomileusis (LASIK) for the treatment of myopic astigmatism." | 3.80 | Effect of mitomycin-C on the variance in refractive outcomes after photorefractive keratectomy. ( Hamilton, DR; Huang, D; Sy, ME; Yeroushalmi, A; Zhang, L, 2014) |
| "To examine the refractive and visual outcome of laser-assisted subepithelial keratomileusis (LASEK) with mitomycin C(MMC) in eyes with myopic astigmatism ≥2." | 3.80 | Laser-assisted subepithelial keratomileusis with mitomycin C for myopic astigmatism ≥2.00 diopters using a Zeiss MEL 80 Excimer. ( Ardjomand, N; El-Shabrawi, Y; Frings, A; Vidic, B, 2014) |
| "To evaluate corneal biomechanical properties and intraocular pressure (IOP) after photorefractive keratectomy (PRK) with or without mitomycin-C (MMC) 0." | 3.78 | Effect of photorefractive keratectomy with mitomycin-C on corneal biomechanical features. ( Azimzadeh, A; Esfandiari, H; Feizi, S; Zare, M, 2012) |
| "To report the use of photorefractive keratectomy (PRK) with mitomycin-C (MMC) to treat concomitant myopia and visually significant infiltrates associated with epidemic keratoconjunctivitis (EKC)." | 3.78 | Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis. ( Alevi, D; Barsam, A; Donnenfeld, ED; Kruh, J; Perry, HD; Prince, J, 2012) |
| "To evaluate the safety and efficacy of photorefractive keratectomy (PRK) with Mitomycin C (MMC) for the treatment of severe pediatric anisometropia and amblyopia resistant to more conservative treatment modalities." | 3.78 | Pediatric PRK (PhotoRefractive Keratectomy) with Mitomycin C (MCC) for Persistent Anisometropic Amblyopia. A Case Report. ( Arnold, RW; Crawford, CM; Frazier, TC; Mazzoli, RA; Raymond, WR; Torres, MF, 2012) |
| "To report topography-guided photorefractive keratectomy (PRK) with mitomycin C (MMC) after penetrating keratoplasty for keratoconus." | 3.75 | Topography-guided (NIDEK customized aspheric treatment zone) photorefractive keratectomy with mitomycin C after penetrating keratoplasty for keratoconus: case report. ( Alves, MR; Barreto, J; Bechara, SJ; Nakano, M; Netto, MV; Reis, A, 2009) |
| "To retrospectively assess risk factors other than high myopia for corneal haze in patients who had conventional photorefractive keratectomy (PRK) without mitomycin-C (MMC)." | 3.74 | Astigmatism: risk factor for postoperative corneal haze in conventional myopic photorefractive keratectomy. ( Brunstetter, T; Rogers, S; Sheridan, MV; Thomas, KE, 2008) |
| "We report a case of controlled buccal pemphigus vulgaris with compound moderate myopia with astigmatism that was treated with photorefractive keratectomy with mitomycin-C (PRK+MMC) in both eyes." | 3.74 | Photorefractive keratectomy with mitomycin-C for the treatment of compound moderate myopia with astigmatism in buccal pemphigus vulgaris. ( Kheiltash, A; Taheri, SM, 2007) |
| "To evaluate the safety and efficacy of photorefractive keratectomy (PRK) with intraoperative mitomycin C (MMC) after deep anterior lamellar keratoplasty (DALK) for keratoconus." | 3.74 | Photorefractive keratectomy with mitomycin C after deep anterior lamellar keratoplasty for keratoconus. ( Leccisotti, A, 2008) |
| "To evaluate the efficacy and safety of prophylactic mitomycin C (MMC) during photorefractive keratectomy (PRK) over LASIK flaps for the treatment of residual refractive errors following LASIK." | 3.74 | Photorefractive keratectomy with 0.02% mitomycin C for treatment of residual refractive errors after LASIK. ( Drake, A; Herzig, S; Srinivasan, S, 2008) |
| "To compare the postoperative pain, visual recovery, and outcomes of flap-on and flap-off epithelial laser in situ keratomileusis (epi-LASIK) with mitomycin-C (MMC)." | 2.76 | Wavefront-guided epithelial laser in situ keratomileusis with mitomycin-C for myopia and myopic astigmatism: flap-on versus flap-off technique. ( Ang, RE; Hernandez, JA; Reyes, KB; Tchah, H, 2011) |
| " New findings regarding the penetration of MMC to the endothelium and into the aqueous humor may lead surgeons to reassess appropriate dosing and patient selection when the drug is used for surgery." | 2.46 | Use of mitomycin-C for phototherapeutic keratectomy and photorefractive keratectomy surgery. ( Shah, RA; Wilson, SE, 2010) |
| "Higher myopia was associated with increased haze severity at 3 months (OR, 1." | 1.56 | Refractive outcomes, corneal haze and endothelial cell loss after myopic photorefractive keratectomy in an Asian population: The Singapore Armed Forces' experience. ( Ang, BCH; Lim, EWL; Nah, GKM; Tan, MCL; Tan, MMH; Toh, ZH; Yap, SC; Zhao, PSB, 2020) |
| "Mitomycin C was applied immediately after laser ablation." | 1.35 | Mitomycin C in photorefractive keratectomy. ( Gimbel, HV; Kaye, GB; Shalaby, A, 2009) |
| " However, for moderate myopia and shallow depth, low dosing appears to be equally effective." | 1.35 | Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia. ( Krueger, RR; Thornton, I; Xu, M, 2008) |
| "Mitomycin C treatment induces apoptosis of keratocytes and myofibroblasts, but the predominate effect in inhibiting or treating haze appears to be at the level of blocked replication of keratocytes or other progenitor cells of myofibroblasts." | 1.33 | Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits. ( Gupta, PC; Mohan, RR; Netto, MV; Sharma, A; Sinha, S; Wilson, SE, 2006) |
| "Mitomycin C was placed in contact with the ablation zone for 75 seconds with an imbibed microsponge." | 1.33 | Comparison of laser epithelial keratomileusis with and without the use of mitomycin C. ( Argento, C; Cosentino, MJ; Ganly, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (2.83) | 18.2507 |
| 2000's | 42 (39.62) | 29.6817 |
| 2010's | 49 (46.23) | 24.3611 |
| 2020's | 12 (11.32) | 2.80 |
| Authors | Studies |
|---|---|
| Hashemi, H | 4 |
| Pakbin, M | 1 |
| Pakravan, M | 1 |
| Fotouhi, A | 2 |
| Jafarzadehpur, E | 1 |
| Aghamirsalim, M | 1 |
| Khabazkhoob, M | 1 |
| Ouerdane, Y | 1 |
| Zaazouee, MS | 1 |
| Mohamed, MEA | 1 |
| Hasan, MT | 1 |
| Hamdy, M | 1 |
| Ghoneim, AM | 1 |
| Gbreel, MI | 1 |
| Ibrahim, AM | 1 |
| Ragab, KM | 1 |
| Nourelden, AZ | 1 |
| Giral, JB | 1 |
| Bloch, F | 1 |
| Sot, M | 1 |
| Zevering, Y | 1 |
| El Nar, A | 1 |
| Vermion, JC | 1 |
| Goetz, C | 1 |
| Lhuillier, L | 1 |
| Perone, JM | 1 |
| Dooling, V | 1 |
| Lappas, A | 1 |
| Dietlein, TS | 1 |
| Seresirikachorn, K | 1 |
| Thiamthat, W | 1 |
| Annopawong, K | 1 |
| Wanichwecharungruang, B | 1 |
| Friedman, DS | 1 |
| Vu, DM | 1 |
| Mohammadi, SF | 2 |
| Abdolahinia, T | 2 |
| Ashrafi, E | 2 |
| Heydari, S | 1 |
| Jamali, S | 1 |
| Ang, BCH | 1 |
| Yap, SC | 1 |
| Toh, ZH | 1 |
| Lim, EWL | 1 |
| Tan, MMH | 1 |
| Nah, GKM | 1 |
| Zhao, PSB | 1 |
| Tan, MCL | 1 |
| Carlos de Oliveira, R | 1 |
| Wilson, SE | 4 |
| Lu, NJ | 1 |
| Koppen, C | 1 |
| Awwad, S | 1 |
| Aslanides, MI | 1 |
| Aslanides, IM | 1 |
| Chen, SH | 2 |
| Sudanaboina, P | 1 |
| Murthy, SI | 1 |
| Rathi, VM | 1 |
| Chang, YM | 1 |
| Liang, CM | 1 |
| Weng, TH | 1 |
| Chien, KH | 1 |
| Lee, CH | 1 |
| Gao, H | 1 |
| Miles, TP | 1 |
| Troche, R | 1 |
| Murdoch, DM | 1 |
| Koefoed, VF | 1 |
| Cason, JB | 2 |
| Cañadas, P | 3 |
| Garcia-Gonzalez, M | 2 |
| Gros-Otero, J | 1 |
| Rodriguez-Perez, I | 2 |
| Cañones-Zafra, R | 1 |
| Teus, MA | 11 |
| Liu, YC | 1 |
| Rosman, M | 1 |
| Mehta, JS | 1 |
| Kaiserman, I | 2 |
| Sadi, N | 1 |
| Mimouni, M | 2 |
| Sela, T | 2 |
| Munzer, G | 2 |
| Levartovsky, S | 1 |
| Iu, LPL | 1 |
| Fan, MCY | 1 |
| Chen, IN | 1 |
| Lai, JSM | 1 |
| Pokroy, R | 1 |
| Siedlecki, J | 1 |
| Luft, N | 1 |
| Kook, D | 1 |
| Wertheimer, C | 1 |
| Mayer, WJ | 1 |
| Bechmann, M | 1 |
| Wiltfang, R | 1 |
| Priglinger, SG | 1 |
| Sekundo, W | 1 |
| Dirisamer, M | 1 |
| Drake Rodriguez-Casanova, P | 1 |
| Rodero, A | 1 |
| Coelho, LM | 1 |
| Sieiro, RO | 1 |
| Adib-Moghaddam, S | 1 |
| Soleyman-Jahi, S | 2 |
| Tefagh, G | 1 |
| Tofighi, S | 1 |
| Grentzelos, MA | 1 |
| Kymionis, GD | 6 |
| Mehlan, J | 1 |
| Linke, SJ | 1 |
| Skevas, C | 1 |
| Steinberg, J | 1 |
| Giannakakis, K | 1 |
| Katz, T | 1 |
| Farahi, A | 1 |
| Mehravaran, S | 2 |
| Frings, A | 1 |
| Vidic, B | 1 |
| El-Shabrawi, Y | 1 |
| Ardjomand, N | 1 |
| Hofmeister, EM | 2 |
| Bishop, FM | 2 |
| Kaupp, SE | 2 |
| Schallhorn, SC | 3 |
| Diakonis, VF | 3 |
| Kankariya, VP | 1 |
| Kounis, G | 1 |
| Pallikaris, AI | 2 |
| Yoo, SH | 2 |
| Pallikaris, IG | 2 |
| Leccisotti, A | 3 |
| Fields, SV | 1 |
| Sia, RK | 1 |
| Ryan, DS | 1 |
| Edwards, JD | 1 |
| Stutzman, RD | 1 |
| Bower, KS | 1 |
| Norouzi, N | 1 |
| Mir-AbouTalebi, M | 1 |
| Jabbarvand, M | 1 |
| Nassiri, N | 4 |
| Sheibani, K | 1 |
| Safi, S | 1 |
| Haghnegahdar, M | 1 |
| Nassiri, S | 1 |
| Panahi, N | 1 |
| Sy, ME | 1 |
| Zhang, L | 1 |
| Yeroushalmi, A | 1 |
| Huang, D | 1 |
| Hamilton, DR | 1 |
| Abdulaal, MR | 1 |
| Wehbe, HA | 1 |
| Awwad, ST | 1 |
| Santhiago, MR | 2 |
| Majmudar, PA | 3 |
| Donaldson, KE | 1 |
| Shtein, RM | 1 |
| Verity, SM | 1 |
| Farjo, AA | 1 |
| Torricelli, AA | 1 |
| Parede, TR | 1 |
| Netto, MV | 5 |
| Crestana, FP | 1 |
| Bechara, SJ | 2 |
| Chan, TCY | 1 |
| Yu, MCY | 1 |
| Mak, S | 1 |
| Jhanji, V | 1 |
| Tanaka, D | 1 |
| Nakanishi, H | 1 |
| Hangai, M | 1 |
| Akagi, T | 1 |
| Morooka, S | 1 |
| Ikeda, HO | 1 |
| Yoshimura, N | 1 |
| Pinheiro, FI | 1 |
| Araújo-Filho, I | 1 |
| Meneses do Rego, AC | 1 |
| Pereira de Azevedo, E | 1 |
| Tabosa do Egito, ES | 1 |
| Oréfice, F | 1 |
| Alves de Souza Lima Filho, A | 1 |
| Salimi, Y | 1 |
| Pir, P | 1 |
| Asgari, S | 1 |
| Chen, WL | 2 |
| Chang, HW | 1 |
| Hu, FR | 2 |
| Barreto, J | 2 |
| Santo, R | 1 |
| Bechara, S | 1 |
| Kara-Jose, N | 1 |
| Charisis, S | 1 |
| Bouzoukis, DI | 1 |
| Naoumidi, I | 1 |
| Tsilimbaris, MK | 1 |
| de Benito-Llopis, L | 8 |
| Hernández-Verdejo, JL | 3 |
| Zhao, LQ | 1 |
| Wei, RL | 1 |
| Ma, XY | 1 |
| Zhu, H | 1 |
| Thomas, KE | 1 |
| Brunstetter, T | 1 |
| Rogers, S | 1 |
| Sheridan, MV | 1 |
| Shalaby, A | 1 |
| Kaye, GB | 1 |
| Gimbel, HV | 1 |
| Reis, A | 1 |
| Nakano, M | 1 |
| Alves, MR | 1 |
| Mohammadpour, M | 1 |
| Koch, DD | 1 |
| Maloney, R | 1 |
| Hardten, DR | 1 |
| Dell, S | 1 |
| Sweeney, AD | 1 |
| Wang, L | 1 |
| Gil-Cazorla, R | 1 |
| Drake, P | 3 |
| Wallau, AD | 2 |
| Campos, M | 2 |
| Kim, ST | 1 |
| Koh, JW | 1 |
| Yoon, GJ | 1 |
| Yang, SW | 1 |
| Virasch, VV | 1 |
| Epstein, RJ | 2 |
| Vaidya, NS | 1 |
| Dennis, RF | 2 |
| Kremer, I | 1 |
| Ehrenberg, M | 1 |
| Levinger, S | 1 |
| Shah, RA | 1 |
| de Benito Llopis, L | 1 |
| Liu, A | 1 |
| Manche, EE | 1 |
| Fernandes, M | 1 |
| Reddy, P | 1 |
| Shah, SG | 1 |
| Feng, YF | 1 |
| Stojanovic, A | 1 |
| Wang, QM | 1 |
| Shen, EP | 1 |
| Hsieh, YT | 1 |
| Yeh, PT | 1 |
| Wang, TJ | 1 |
| Gambato, C | 3 |
| Catania, AG | 1 |
| Vujosevic, S | 1 |
| Midena, E | 3 |
| Ang, RE | 1 |
| Reyes, KB | 1 |
| Hernandez, JA | 1 |
| Tchah, H | 1 |
| Drake-Casanova, P | 1 |
| Huisingh, C | 1 |
| McGwin, G | 1 |
| Zare, M | 1 |
| Feizi, S | 1 |
| Azimzadeh, A | 1 |
| Esfandiari, H | 1 |
| Alevi, D | 1 |
| Barsam, A | 1 |
| Kruh, J | 1 |
| Prince, J | 1 |
| Perry, HD | 1 |
| Donnenfeld, ED | 1 |
| Gomes, BA | 1 |
| Smadja, D | 1 |
| Espana, EM | 1 |
| Ahn, ES | 1 |
| Zhang, Y | 1 |
| Chen, YG | 1 |
| Xia, YJ | 1 |
| Qi, H | 1 |
| Shojaei, A | 1 |
| Ramezanzadeh, M | 1 |
| Almasi-Nasrabadi, M | 1 |
| Rezazadeh, P | 1 |
| Eslani, M | 1 |
| Crawford, CM | 1 |
| Frazier, TC | 1 |
| Torres, MF | 1 |
| Arnold, RW | 1 |
| Mazzoli, RA | 1 |
| Raymond, WR | 1 |
| Carones, F | 1 |
| Vigo, L | 1 |
| Scandola, E | 1 |
| Vacchini, L | 1 |
| Taheri, SM | 2 |
| Kheiltash, A | 2 |
| Ghirlando, A | 2 |
| Moretto, E | 1 |
| Busato, F | 1 |
| Kottler, UB | 1 |
| Dick, HB | 1 |
| Lee, DH | 1 |
| Chung, HS | 1 |
| Jeon, YC | 1 |
| Boo, SD | 1 |
| Yoon, YD | 1 |
| Kim, JG | 1 |
| Mohan, RR | 1 |
| Sinha, S | 1 |
| Sharma, A | 1 |
| Gupta, PC | 1 |
| Rajan, MS | 1 |
| O'Brart, DP | 1 |
| Patmore, A | 1 |
| Marshall, J | 1 |
| Argento, C | 1 |
| Cosentino, MJ | 1 |
| Ganly, M | 1 |
| Randleman, JB | 2 |
| Loft, ES | 1 |
| Banning, CS | 1 |
| Lynn, MJ | 1 |
| Stulting, RD | 1 |
| Nassaralla, BA | 1 |
| McLeod, SD | 1 |
| Nassaralla, JJ | 1 |
| Pallikaris, A | 1 |
| Markomanolakis, MM | 1 |
| Ortega, M | 1 |
| Cheng, AC | 1 |
| Wong, VW | 1 |
| Rao, SK | 1 |
| Lam, DS | 1 |
| Thornton, I | 2 |
| Puri, A | 1 |
| Xu, M | 2 |
| Krueger, RR | 3 |
| Goldsberry, DH | 1 |
| Epstein, RH | 1 |
| Holley, G | 1 |
| Edelhauser, HF | 1 |
| Miotto, S | 1 |
| Cortese, M | 1 |
| Salvi, R | 1 |
| Gamaly, TO | 1 |
| El Danasoury, A | 1 |
| El Maghraby, A | 1 |
| Lacayo, GO | 1 |
| Srinivasan, S | 1 |
| Drake, A | 1 |
| Herzig, S | 1 |
| Sánchez-Pina, JM | 1 |
| Fuentes, I | 1 |
| Farahangiz, S | 1 |
| Rahnavardi, M | 1 |
| Rahmani, L | 1 |
| Utz, VM | 1 |
| Gupta, N | 1 |
| Weinreb, RN | 1 |
| Morales, J | 1 |
| Good, D | 1 |
| Cheng, Z | 1 |
| Li, J | 1 |
| Cai, K | 1 |
| Li, R | 1 |
| Li, H | 1 |
| Qin, X | 1 |
| Maldonado, MJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1 Study of in Vivo Confocal Microscope to Evaluate the Corneal Wound Healing After Various Ocular Surgeries[NCT00491439] | 120 participants (Actual) | Observational | 2007-04-30 | Completed | |||
| Two Years Follow up of Corneal Cor Cross-linking and Refractive Surface Ablation in Patients With Asymmetric Corneal Topography[NCT02943967] | 44 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| Anterior Stromal Changes After PRK by Using Intraoperative Mitomicin C.[NCT00599950] | Phase 4 | 10 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| Epi-LASIK : A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma.[NCT00599690] | 10 participants (Actual) | Interventional | 2006-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for mitomycin and Myopia
| Article | Year |
|---|---|
Mitomycin C application after photorefractive keratectomy in high, moderate, or low myopia: Systematic review and meta-analysis.
Topics: Alkylating Agents; Humans; Lasers, Excimer; Mitomycin; Myopia; Photorefractive Keratectomy | 2021 |
Biological effects of mitomycin C on late corneal haze stromal fibrosis following PRK.
Topics: Alkylating Agents; Corneal Opacity; Corneal Stroma; Fibrosis; Humans; Lasers, Excimer; Mitomycin; My | 2020 |
Mitomycin C for the prevention of corneal haze in photorefractive keratectomy: a meta-analysis and trial sequential analysis.
Topics: Corneal Opacity; Cross-Linking Reagents; Humans; Mitomycin; Myopia; Photorefractive Keratectomy; Pos | 2021 |
Mitomycin-C in corneal surface excimer laser ablation techniques: a report by the American Academy of Ophthalmology.
Topics: Academies and Institutes; Alkylating Agents; Combined Modality Therapy; Cornea; Corneal Surgery, Las | 2015 |
Use of mitomycin-C for phototherapeutic keratectomy and photorefractive keratectomy surgery.
Topics: Alkylating Agents; Animals; Astigmatism; Combined Modality Therapy; Corneal Opacity; Humans; Hyperop | 2010 |
Meta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02% mitomycin C.
Topics: Alkylating Agents; Cornea; Corneal Topography; Dose-Response Relationship, Drug; Humans; Keratectomy | 2011 |
[Mitomycin C in refractive corneal surface surgery with the excimer laser: first experience and review of the literature].
Topics: Adult; Antibiotics, Antineoplastic; Chemotherapy, Adjuvant; Corneal Opacity; Humans; Intracellular S | 2005 |
Surface ablation.
Topics: Alkylating Agents; Corneal Stroma; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Mitomycin | 2008 |
24 trials available for mitomycin and Myopia
| Article | Year |
|---|---|
Effect of Short Versus Long-Term Steroid on Corneal Haze After Photorefractive Keratectomy: A Randomized, Double-Masked Clinical Trial.
Topics: Adult; Fluorometholone; Humans; Lasers, Excimer; Mitomycin; Myopia; Photorefractive Keratectomy; Pro | 2022 |
Long-term effects of mitomycin-C on residual aberration and optical quality after photorefractive keratectomy in eyes with low to moderate myopia.
Topics: Adolescent; Adult; Alkylating Agents; Contrast Sensitivity; Corneal Wavefront Aberration; Female; Fo | 2019 |
Effect of intraoperative mitomycin-C application on epithelial regeneration after transepithelial photorefractive keratectomy.
Topics: Alkylating Agents; China; Humans; Lasers, Excimer; Mitomycin; Myopia; Photorefractive Keratectomy; P | 2021 |
The effects of mitomycin C on tear function after photorefractive keratectomy: a contralateral comparative study.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Stroma; Double-Blind Method; Fluorophot | 2013 |
Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.
Topics: Adult; Alkylating Agents; Cell Count; Corneal Endothelial Cell Loss; Corneal Opacity; Dose-Response | 2013 |
Contralateral-eye study of surface refractive treatments: clinical and confocal microscopy evaluation.
Topics: Adult; Alkylating Agents; Cell Count; Combined Modality Therapy; Cornea; Corneal Keratocytes; Endoth | 2014 |
The U.S. Army Surface Ablation Study: comparison of PRK, MMC-PRK, and LASEK in moderate to high myopia.
Topics: Adult; Alkylating Agents; Cell Count; Combined Modality Therapy; Cornea; Endothelium, Corneal; Femal | 2014 |
Effects of mitomycin-C on tear film, corneal biomechanics, and surface irregularity in mild to moderate myopic surface ablation: preliminary results.
Topics: Adult; Alkylating Agents; Biomechanical Phenomena; Cornea; Double-Blind Method; Elasticity; Female; | 2014 |
Alcohol-assisted debridement in PRK with intraoperative mitomycin C.
Topics: Adult; Alkylating Agents; Cell Count; Corneal Keratocytes; Corneal Stroma; Debridement; Endothelium, | 2014 |
Intraocular straylight before and after low myopic photorefractive keratectomy with and without mitomycin C.
Topics: Administration, Ophthalmic; Adult; Corneal Diseases; Corneal Wavefront Aberration; Cross-Linking Rea | 2016 |
One-year outcomes of a bilateral randomised prospective clinical trial comparing PRK with mitomycin C and LASIK.
Topics: Adult; Biomechanical Phenomena; Combined Modality Therapy; Contrast Sensitivity; Cornea; Corneal Opa | 2009 |
Wavefront-guided epithelial laser in situ keratomileusis with mitomycin-C for myopia and myopic astigmatism: flap-on versus flap-off technique.
Topics: Aberrometry; Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Contrast Sensitivity; | 2011 |
[Effect of mitomycin C on corneal regrowth after laser-assisted sub-epithelial keratectomy (LASEK)].
Topics: Adult; Cell Division; Corneal Opacity; Female; Fibroblasts; Growth Inhibitors; Humans; Intraoperativ | 2011 |
Comparison of Tear cytokines and clinical outcomes between off-flap and on-flap epi-LASIK with mitomycin C.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Cytokines; Double-Blind Method; Eye Pain; Eye P | 2012 |
Short-time mitomycin-C application during photorefractive keratectomy in patients with low myopia.
Topics: Adult; Alkylating Agents; Cell Count; Cornea; Corneal Opacity; Double-Blind Method; Endothelium, Cor | 2013 |
Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Cornea; Corneal Opacity; Double-Blind M | 2002 |
Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy in high myopia: a prospective clinical study.
Topics: Adult; Antibiotics, Antineoplastic; Corneal Opacity; Humans; Lasers, Excimer; Middle Aged; Mitomycin | 2004 |
Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes.
Topics: Administration, Topical; Adult; Antibiotics, Antineoplastic; Contrast Sensitivity; Cornea; Corneal O | 2005 |
Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin.
Topics: Alkylating Agents; Cell Count; Combined Modality Therapy; Double-Blind Method; Endothelium, Corneal; | 2007 |
Long-term effects on corneal keratocytes of mitomycin C during photorefractive keratectomy: a randomized contralateral eye confocal microscopy study.
Topics: Administration, Topical; Adult; Cell Count; Cornea; Corneal Opacity; Double-Blind Method; Female; Hu | 2007 |
A prospective, randomized, contralateral eye comparison of epithelial laser in situ keratomileusis and photorefractive keratectomy in eyes prone to haze.
Topics: Adult; Corneal Opacity; Epithelium, Corneal; Female; Humans; Keratomileusis, Laser In Situ; Lasers, | 2007 |
Mitomycin C in photorefractive keratectomy: effect on epithelialization and predictability.
Topics: Administration, Topical; Adult; Alkylating Agents; Combined Modality Therapy; Double-Blind Method; E | 2008 |
Corneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trial.
Topics: Adolescent; Adult; Alkylating Agents; Cell Count; Cell Survival; Corneal Diseases; Endothelium, Corn | 2008 |
Photorefractive keratectomy with mitomycin C versus LASIK in custom surgeries for myopia: a bilateral prospective randomized clinical trial.
Topics: Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Contrast Sensitivity; Double-Blind | 2008 |
74 other studies available for mitomycin and Myopia
| Article | Year |
|---|---|
Efficacy and safety of single-step transepithelial photorefractive keratectomy with the all-surface laser ablation SCHWIND platform without mitomycin-C for high myopia: A retrospective study of 69 eyes.
Topics: Adult; Female; Humans; Lasers, Excimer; Male; Mitomycin; Myopia; Photorefractive Keratectomy; Prospe | 2021 |
Is canaloplasty with mitomycin c a safe procedure in myopic glaucoma?
Topics: Choroidal Effusions; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Myopia | 2022 |
Treatment Outcomes for Juvenile Open Angle Glaucoma in Thailand.
Topics: Adolescent; Adult; Child; Child, Preschool; Cornea; Female; Follow-Up Studies; Glaucoma; Glaucoma, O | 2023 |
Refractive outcomes, corneal haze and endothelial cell loss after myopic photorefractive keratectomy in an Asian population: The Singapore Armed Forces' experience.
Topics: Cornea; Endothelial Cells; Humans; Lasers, Excimer; Male; Mitomycin; Myopia; Photorefractive Keratec | 2020 |
Excimer laser phototherapeutic keratectomy with mitomycin C application to treat haze after myopic photorefractive keratectomy.
Topics: Alkylating Agents; Corneal Opacity; Humans; Lasers, Excimer; Mitomycin; Myopia; Photorefractive Kera | 2020 |
Quality of Vision Following LASIK and PRK-MMC for Treatment of Myopia.
Topics: Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Mitomycin; Myopia; Photorefractive Keratecto | 2022 |
Effect of Laser-assisted Subepithelial Keratectomy with Mitomycin C on Corneal Optical Density Measured with Confocal Microscopy.
Topics: Adult; Alkylating Agents; Biometry; Combined Modality Therapy; Cornea; Corneal Stroma; Female; Human | 2021 |
Enhancement after Small-Incision Lenticule Extraction: Incidence, Risk Factors, and Outcomes.
Topics: Adult; Alkylating Agents; Cohort Studies; Corneal Stroma; Corneal Surgery, Laser; Female; Humans; In | 2017 |
Corneal Breakthrough Haze After Photorefractive Keratectomy With Mitomycin C: Incidence and Risk Factors.
Topics: Adult; Alkylating Agents; Corneal Opacity; Female; Humans; Hyperopia; Incidence; Lasers, Excimer; Ma | 2017 |
Predictability and stability of laser-assisted subepithelial keratectomy with mitomycin C for the correction of high myopia.
Topics: Adult; Combined Modality Therapy; Female; Hong Kong; Humans; Keratectomy, Subepithelial, Laser-Assis | 2017 |
Predictors of myopic photorefractive keratectomy retreatment.
Topics: Adult; Alkylating Agents; Female; Humans; Male; Mitomycin; Myopia; Photorefractive Keratectomy; Retr | 2017 |
Enhancement After Myopic Small Incision Lenticule Extraction (SMILE) Using Surface Ablation.
Topics: Administration, Topical; Adult; Corneal Stroma; Corneal Surgery, Laser; Cross-Linking Reagents; Feas | 2017 |
Long-term Follow-up of LASEK With Mitomycin C Performed to Correct Myopia in Thin Corneas.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Cornea; Corneal Pachymetry; Corneal Topography; | 2017 |
Mitomycin C 0.02 and 0.002% efficacy in preventing haze after photorefractive keratectomy.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Dose-Response Relationship, Drug; Female; Foll | 2019 |
Comparison of Single-Step Transepithelial Photorefractive Keratectomy With or Without Mitomycin C in Mild to Moderate Myopia.
Topics: Adult; Alkylating Agents; Cell Count; Contrast Sensitivity; Corneal Wavefront Aberration; Endotheliu | 2018 |
Safety and complications after three different surface ablation techniques with mitomycin C: a retrospective analysis of 2757 eyes.
Topics: Administration, Topical; Adult; Female; Humans; Intraoperative Period; Lasers, Excimer; Male; Mitomy | 2019 |
Laser-assisted subepithelial keratomileusis with mitomycin C for myopic astigmatism ≥2.00 diopters using a Zeiss MEL 80 Excimer.
Topics: Adult; Alkylating Agents; Astigmatism; Female; Humans; Keratomileusis, Laser In Situ; Lasers, Excime | 2014 |
Reply: To PMID 23830559.
Topics: Alkylating Agents; Corneal Opacity; Female; Humans; Lasers, Excimer; Male; Mitomycin; Myopia; Photor | 2014 |
Mitomycin-C in photorefractive keratectomy.
Topics: Alkylating Agents; Corneal Opacity; Female; Humans; Lasers, Excimer; Male; Mitomycin; Myopia; Photor | 2014 |
Effect of mitomycin-C on the variance in refractive outcomes after photorefractive keratectomy.
Topics: Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Corneal Stroma; Humans; Keratomile | 2014 |
One-step transepithelial photorefractive keratectomy with mitomycin C as an early treatment for LASIK flap buttonhole formation.
Topics: Adult; Cross-Linking Reagents; Female; Follow-Up Studies; Humans; Keratomileusis, Laser In Situ; Mal | 2015 |
Refractive surgical problem: December consultation #1.
Topics: Adult; Alkylating Agents; Corneal Endothelial Cell Loss; Endothelium, Corneal; Epikeratophakia; Fema | 2014 |
Longitudinal comparison of femtosecond-assisted sub-Bowman keratomileusis versus photorefractive keratectomy for high myopia.
Topics: Adult; Analysis of Variance; Cornea; Female; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; | 2017 |
Influence of high myopia on outcomes of trabeculectomy with mitomycin C in patients with primary open-angle glaucoma.
Topics: Aged; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Ag | 2016 |
New drug delivery system for corneal administration of mitomycin-C.
Topics: Alkylating Agents; Drug Delivery Systems; Humans; Lasers, Excimer; Mitomycin; Myopia; Perioperative | 2016 |
Photorefractive Keratectomy With Mitomycin-C for High Myopia: Three Year Follow-Up Results.
Topics: Adult; Contrast Sensitivity; Cornea; Female; Follow-Up Studies; Humans; Lasers, Excimer; Male; Mitom | 2017 |
In vivo confocal microscopic evaluation of corneal wound healing after epi-LASIK.
Topics: Adult; Alkylating Agents; Astigmatism; Epithelium, Corneal; Humans; Keratomileusis, Laser In Situ; L | 2008 |
Synergistic effect of ethanol and mitomycin C on corneal stroma.
Topics: Actins; Animals; Cell Count; Corneal Stroma; Drug Combinations; Drug Synergism; Epithelium, Corneal; | 2008 |
Effects of topical mitomycin C on the ciliary body and intraocular pressure after PRK: an experimental study.
Topics: Administration, Topical; Alkylating Agents; Animals; Ciliary Body; Intraocular Pressure; Lasers, Exc | 2008 |
Comparison between three- and six-month postoperative refractive and visual results after laser epithelial keratomileusis with mitomycin C.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Keratectomy, | 2009 |
Effect of intraoperative mitomycin-C on healthy corneal endothelium after laser-assisted subepithelial keratectomy.
Topics: Adolescent; Adult; Alkylating Agents; Astigmatism; Cell Count; Endothelium, Corneal; Female; Follow- | 2008 |
Astigmatism: risk factor for postoperative corneal haze in conventional myopic photorefractive keratectomy.
Topics: Adult; Alkylating Agents; Astigmatism; Corneal Opacity; Female; Humans; Lasers, Excimer; Male; Middl | 2008 |
Mitomycin C in photorefractive keratectomy.
Topics: Alkylating Agents; Combined Modality Therapy; Cornea; Corneal Opacity; Humans; Lasers, Excimer; Mito | 2009 |
Topography-guided (NIDEK customized aspheric treatment zone) photorefractive keratectomy with mitomycin C after penetrating keratoplasty for keratoconus: case report.
Topics: Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Corneal Topography; Female; Humans | 2009 |
Photorefractive keratectomy with and without mitomycin-C.
Topics: Humans; Mitomycin; Myopia; Photorefractive Keratectomy | 2009 |
Wavefront-guided photorefractive keratectomy in eyes with prior radial keratotomy: a multicenter study.
Topics: Adult; Combined Modality Therapy; Corneal Topography; Female; Follow-Up Studies; Humans; Hyperopia; | 2009 |
Comparison between femtosecond laser-assisted sub-Bowman keratomileusis vs laser subepithelial keratectomy to correct myopia.
Topics: Adolescent; Adult; Corneal Surgery, Laser; Follow-Up Studies; Humans; Keratectomy, Subepithelial, La | 2009 |
Clinical outcomes of epi-LASIK: 1-year results of on- and off-flap procedures with and without mitomycin-C.
Topics: Adult; Corneal Opacity; Corneal Topography; Female; Humans; Keratomileusis, Laser In Situ; Male; Mit | 2010 |
Reduced application time for prophylactic mitomycin C in photorefractive keratectomy.
Topics: Adult; Alkylating Agents; Corneal Opacity; Female; Humans; Lasers, Excimer; Male; Mitomycin; Myopia; | 2010 |
Delayed epithelial healing following photorefractive keratectomy with mitomycin C treatment.
Topics: Adolescent; Adult; Alkylating Agents; Anti-Bacterial Agents; Combined Modality Therapy; Debridement; | 2012 |
Efficacy of surface ablation retreatments using mitomycin C.
Topics: Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Cornea; Humans; Intraoperative Com | 2010 |
Keratocyte density after laser-assisted subepithelial keratectomy with mitomycin C.
Topics: Adult; Alkylating Agents; Cell Count; Combined Modality Therapy; Corneal Stroma; Follow-Up Studies; | 2010 |
Visually significant haze after retreatment with photorefractive keratectomy with mitomycin-C following laser in situ keratomileusis.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Opacity; Female; Humans; Keratomileusis | 2010 |
One-year outcome of bilateral randomised prospective clinical trial comparing photorefractive keratectomy (PRK) with mitomycin C (MMC) and laser in situ keratomileusis (LASIK).
Topics: Combined Modality Therapy; Humans; Keratomileusis, Laser In Situ; Mitomycin; Myopia; Nucleic Acid Sy | 2011 |
Comparison of in vivo confocal microscopic findings between epi-LASIK procedures with different management of the epithelial flaps.
Topics: Adult; Alkylating Agents; Astigmatism; Epithelium, Corneal; Female; Humans; Keratomileusis, Laser In | 2011 |
Wavefront-optimized surface ablation with the Allegretto Wave Eye-Q excimer laser platform: 12-month visual and refractive results.
Topics: Adult; Algorithms; Alkylating Agents; Astigmatism; Cornea; Female; Humans; Lasers, Excimer; Male; Mi | 2011 |
Keratocyte density 3 months, 15 months, and 3 years after corneal surface ablation with mitomycin C.
Topics: Adult; Alkylating Agents; Astigmatism; Cell Count; Combined Modality Therapy; Corneal Keratocytes; C | 2012 |
Keratocyte density 3 months, 15 months, and 3 years after corneal surface ablation with mitomycin C.
Topics: Alkylating Agents; Corneal Keratocytes; Humans; Keratectomy, Subepithelial, Laser-Assisted; Lasers, | 2012 |
Effect of photorefractive keratectomy with mitomycin-C on corneal biomechanical features.
Topics: Adult; Alkylating Agents; Biomechanical Phenomena; Combined Modality Therapy; Cornea; Elasticity; Fe | 2012 |
Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis.
Topics: Aberrometry; Adenoviridae; Adenovirus Infections, Human; Administration, Topical; Adult; Alkylating | 2012 |
Very late-onset corneal scar triggered by trauma after photorefractive keratectomy.
Topics: Alkylating Agents; Cornea; Corneal Injuries; Corneal Opacity; Eye Injuries; Female; Glucocorticoids; | 2012 |
Pediatric PRK (PhotoRefractive Keratectomy) with Mitomycin C (MCC) for Persistent Anisometropic Amblyopia. A Case Report.
Topics: Amblyopia; Child; Humans; Lasers, Excimer; Mitomycin; Myopia; Photorefractive Keratectomy; Prospecti | 2012 |
Mitomycin C in highly myopic eyes.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Cornea; Corneal Opacity; Humans; Lasers, Excim | 2006 |
Photorefractive keratectomy with intraoperative mitomycin-C application.
Topics: Adult; Antibiotics, Antineoplastic; Combined Modality Therapy; Cornea; Female; Humans; Intraoperativ | 2005 |
Effect of prophylactic and therapeutic mitomycin C on corneal apoptosis, cellular proliferation, haze, and long-term keratocyte density in rabbits.
Topics: Animals; Apoptosis; Cell Count; Cell Proliferation; Cornea; Corneal Opacity; Disease Models, Animal; | 2006 |
Cellular effects of mitomycin-C on human corneas after photorefractive keratectomy.
Topics: Alkylating Agents; Cell Movement; Cornea; Epithelial Cells; Fibroblasts; Humans; Lasers, Excimer; Mi | 2006 |
Comparison of laser epithelial keratomileusis with and without the use of mitomycin C.
Topics: Adult; Antibiotics, Antineoplastic; Epithelium, Corneal; Female; Follow-Up Studies; Humans; Incidenc | 2006 |
Outcomes of wavefront-optimized surface ablation.
Topics: Adult; Alkylating Agents; Cornea; Female; Humans; Keratectomy, Subepithelial, Laser-Assisted; Kerato | 2007 |
Prophylactic mitomycin C to inhibit corneal haze after photorefractive keratectomy for residual myopia following radial keratotomy.
Topics: Adult; Alkylating Agents; Cell Count; Corneal Opacity; Endothelium, Corneal; Female; Humans; Keratot | 2007 |
Effect of mitomycin-C on the corneal endothelium during excimer laser surface ablation.
Topics: Adult; Alkylating Agents; Cell Count; Endothelium, Corneal; Follow-Up Studies; Humans; Keratectomy, | 2007 |
Repositioning of free cap four days after LASIK.
Topics: Adult; Cornea; Drug Therapy, Combination; Humans; Intraoperative Complications; Keratomileusis, Lase | 2007 |
Laser-assisted subepithelial keratectomy with MMC to treat post-LASIK myopic regression.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Cornea; Female; Humans; Keratectomy, Subepithel | 2007 |
Photorefractive keratectomy with mitomycin-C for the treatment of compound moderate myopia with astigmatism in buccal pemphigus vulgaris.
Topics: Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Female; Humans; Lasers, Excimer; M | 2007 |
Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation.
Topics: Adolescent; Adult; Cornea; Corneal Opacity; Female; Follow-Up Studies; Humans; Keratectomy, Subepith | 2007 |
Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy.
Topics: Cell Count; Corneal Opacity; Endothelium, Corneal; Humans; Lasers, Excimer; Mitomycin; Myopia; Nucle | 2007 |
Photorefractive keratectomy with 0.02% mitomycin C for treatment of residual refractive errors after LASIK.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Female; Humans; Keratomileusis, Laser In Situ; | 2008 |
Comparison of standard (0.02%) and low dose (0.002%) mitomycin C in the prevention of corneal haze following surface ablation for myopia.
Topics: Adult; Alkylating Agents; Corneal Opacity; Humans; Lasers, Excimer; Mitomycin; Myopia; Photorefracti | 2008 |
Stability of laser epithelial keratomileusis with and without mitomycin C performed to correct myopia in thin corneas: a 15-month follow-up.
Topics: Adult; Alkylating Agents; Combined Modality Therapy; Cornea; Female; Follow-Up Studies; Humans; Kera | 2008 |
Photorefractive keratectomy with mitomycin C after deep anterior lamellar keratoplasty for keratoconus.
Topics: Adult; Alkylating Agents; Astigmatism; Cell Count; Combined Modality Therapy; Corneal Topography; Co | 2008 |
Management of irregular astigmatism following rotationally disoriented free cap after LASIK.
Topics: Adult; Alkylating Agents; Astigmatism; Combined Modality Therapy; Corneal Stroma; Corneal Topography | 2008 |
Filtering bleb infection as a complication of orthokeratology.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Contact Lenses; Drug Therapy, Combination | 1997 |
Permanent glaucomatous visual loss after photorefractive keratectomy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Cornea; Dexamethasone; Filtering Surgery; | 1998 |
[Effects of mitomycin C on haze after photorefractive keratectomy for myopia in rabbits].
Topics: Animals; Dexamethasone; Female; Lasers, Excimer; Male; Microscopy, Electron, Scanning; Mitomycin; My | 1998 |
Intraoperative MMC after excimer laser surgery for myopia.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Epithelium, Corneal; Fibrosis; Humans; Intraop | 2002 |